Pediatric inflammatory bowel disease and bone health

Nutrition in Clinical Practice

Volumn 25, Issue 4, 2010, Pages 347-352

  Mascarenhas, Maria R ^a   Thayu, Meena ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bone diseases; Crohng's disease; inflammatory bowel diseases; metabolic; pediatrics

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCIUM; CALCIUM OXALATE; ERGOCALCIFEROL; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN K GROUP; ZINC;

BONE DENSITY; BONE DISEASE; BONE FRAGILITY; BONE MINERALIZATION; BONE TUMOR; CACHEXIA; CALCIUM DEFICIENCY; CALCIUM INTAKE; COMPRESSION FRACTURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; HUMAN; HYPEROXALURIA; JAW TUMOR; NEPHROLITHIASIS; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; OSTEOPOROSIS; OVARY DISEASE; POSTMENOPAUSE OSTEOPOROSIS; RESISTANCE TRAINING; REVIEW; RISK FACTOR; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; WEIGHT BEARING; ZINC DEFICIENCY;

BONE DISEASES; CALCIUM, DIETARY; CHILD; DIPHOSPHONATES; EXERCISE; HUMANS; INFLAMMATORY BOWEL DISEASES; MICRONUTRIENTS; PEDIATRICS; VITAMIN D;

EID: 78649305012     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533610374962     Document Type: Review

References (65)

1. Bailey DA, Mckay HA, Mirwald RL, Crocker PR, Faulkner RA A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study. J Bone Miner Res. 1999 ; 14: 1672-1679.
2. Semeao EJ, Jawad AF, Stouffer NO, Zemel BS, Piccoli DA, Stallings VA Bone mineral density in children and young adults with Crohng's disease. Inflamm Bowel Dis. 1999 ; 5: 161-166.
3. Dubner SE, Shults J., Baldassano RN, et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohng's disease. Gastroenterology. 2009 ; 136: 123-130.
4. Sylvester FA, Wyzga N., Hyams JS, et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis. 2007 ; 13: 42-50.
5. Gilbert L., He X., Farmer P., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology. 2000 ; 141: 3956-3964.
6. Lee SE, Chung WJ, Kwak HB, et al. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem. 2001 ; 276: 49343-49349.
7. Kong YY, Feige U., Sarosi I., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999 ; 402: 304-309.
8. Walsh MC, Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 2003 ; 14: 251-263.
9. Kudo O., Sabokbar A., Pocock A., Itonaga I., Fujikawa Y., Athanasou NA Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone. 2003 ; 32: 1-7.
10. Gilbert L., He X., Farmer P., et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem. 2002 ; 277: 2695-2701.
11. Radeff JM, Nagy Z., Stern PH Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Exp Cell Res. 2001 ; 268: 179-188.
12. Pereira RC, Delany AM, Canalis E. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone. 2002 ; 30: 685-691.
13. Canalis E., Bilezikian JP, Angeli A., Giustina A. Perspectives on glucocorticoid-induced osteoporosis. Bone. 2004 ; 34: 593-598.
14. Abreu MT, Geller JL, Vasiliauskas EA, et al. Treatment with infliximab is associated with increased markers of bone formation in patients with Crohng's disease. J Clin Gastroenterol. 2006 ; 40: 55-63.
15. Bernstein M., Irwin S., Greenberg GR Maintenance infliximab treatment is associated with improved bone mineral density in Crohng's disease. Am J Gastroenterol. 2005 ; 100: 2031-2035.
16. Thayu M., Leonard MB, Hyams JS, et al. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohng's disease: results of the REACH study. Clin Gastroenterol Hepatol. 2008 ; 6: 1378-1384.
17. Szulc P., Chapuy MC, Meunier PJ, Delmas PD Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993 ; 91: 1769-1774.
18. Hildebrand H., Karlberg J., Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1994 ; 18: 165-173. (Pubitemid 24056474)
19. Burnham JM, Shults J., Semeao E., et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr. 2005 ; 82: 413-420.
20. Burnham JM, Shults J., Semeao E., et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004 ; 19: 1961-1968.
21. Thayu M., Shults J., Burnham JM, et al. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohng's disease. Inflamm Bowel Dis. 2007 ; 13: 1121-1128.
22. Thayu M., Shults J., Burnham JM, Zemel BS, Baldassano RN, Leonard MB Risk factors for low bone mineral density in children and young adults with Crohng's disease. J Pediatr. 1999 ; 135: 593-600.
23. Pollak RD, Karmeli F., Eliakim R., Ackerman Z., Tabb K., Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998 ; 93: 1483-1490.
24. Bischoff SC, Herrmann A., Gäpara;ke M., Manns MP, von zur Mühlen A., Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 1997 ; 92: 1157-1163.
25. Semeao E., Stallings V., Peck S., Piccoli D. Vertebral compression fractures in pediatric patients with Crohng's disease. Gastroenterology. 1997 ; 112: 1710-1713.
26. Thearle M., Horlick M., Bilezikian JP, et al. Osteoporosis: an unusual presentation of childhood Crohng's disease. J Clin Endocrinol Metab. 2000 ; 85: 2122-2126.
27. van Staa TP, Cooper C., Brusse LS, Leufkens H., Javaid MK, Arden NK Inflammatory bowel disease and the risk of fracture. Gastroenterology. 2003 ; 125: 1591-1597.
28. Bernstein CN, Blanchard JF, Leslie W., Wajda A., Yu BN The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study. Ann Intern Med. 2000 ; 133: 795-799.
29. Loftus EV Jr, Crowson CS, Sandborn WJ, Tremaine WJ, Og'Fallon WM, Melton LJ III. Long-term fracture risk in patients with Crohng's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology. 2002 ; 123: 468-475.
30. Gafni RI, Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr. 2004 ; 144: 253-257.
31. Stephens M., Batres LA, Ng D., Baldassano R. Growth failure in the child with inflammatory bowel disease. Semin Gastrointest Dis. 2001 ; 12: 253-262.
32. Gilsanz V. Bone density in children: a review of the available techniques and indications. Eur J Radiol. 1998 ; 26: 177-182.
33. Baim S., Leonard MB, Bianchi ML Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom. 2008 ; 11: 6-21.
34. Fell JM, Paintin M., Arnaud-Battandier F., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Chrohng's disease. Aliment Pharmacol Ther. 2000 ; 14: 281-289.
35. Borrelli O., Cordischi L., Cirulli M., et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohng's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol. 2006 ; 4: 744-753.
36. Newby EA, Sawczenko A., Thomas AG, Wilson D. Interventions for growth failure in childhood Crohng's disease. Cochrane Database Syst Rev. 2005 ;(3). CD003873.
37. Cadogan J., Eastell R., Jones N., Barker ME Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ. 1997 ; 315: 1255-1260.
38. Bonjour JP, Carrie AL, Ferrari S., et al. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest. 1997 ; 99: 1287-1294.
39. Alaimo K., McDowell MA, Briefel RR, et al. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv Data. 1994 ;(258). 1-28.
40. Benchimol EI, Ward LM, Gallagher JC, et al. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007 ; 45: 538-545.
41. Specker B., Binkley T. Randomized trial of physical activity and calcium supplementation on bone mineral content in 3- to 5-year-old children. J Bone Miner Res. 2003 ; 18: 885-892.
42. Specker BL Evidence for an interaction between calcium intake and physical activity on changes in bone mineral density. J Bone Miner Res. 1996 ; 11: 1539-1544.
43. Iuliano-Burns S., Saxon L., Naughton G., Gibbons K., Bass SL Regional specificity of exercise and calcium during skeletal growth in girls: a randomized controlled trial. J Bone Miner Res. 2003 ; 18: 156-162.
44. Misra M., Pacaud D., Petryk A., Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008 ; 122: 398-417.
45. Wagner CL, Greer FR Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008 ; 122: 1142-1152.
46. Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. In: Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, DC: National Academy Press ; 1997.
47. Peterlik M., Cross HS Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr. 2009 ; 63: 1377-1386.
48. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003 ; 22: 142-146.
49. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003 ; 77: 204-210.
50. Armas LA, Hollis BW, Heaney RP Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004 ; 89: 5387-5391.
51. Gordon CM, Williams AL, Feldman HA, et al. Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab. 2008 ; 93: 2716-2721.
52. Kuwabara K., Matsuda S., Fushimi K., Ishikawa KB, Horiguchi H., Fujimori K. Hospital volume and quality of laparoscopic gastrectomy in Japan. Dig Surg. 2009 ; 26: 422-429.
53. Parfitt AM The two faces of growth: benefits and risks to bone integrity. Osteoporos Int. 1994 ; 4: 382-398.
54. Janz KF Validation of the CSA accelerometer for assessing childreng's physical activity. Med Sci Sports Exerc. 1994 ; 26: 369-375.
55. Bass S., Pearce G., Bradney M., et al. Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts. J Bone Miner Res. 1998 ; 13: 500-507.
56. Bass SL, Saxon L., Daly RM, et al. The effect of mechanical loading on the size and shape of bone in pre-, peri-, and postpubertal girls: a study in tennis players. J Bone Miner Res. 2002 ; 17: 2274-2280.
57. Bass S., Pearce G., Young N., Seeman E. Bone mass during growth: the effects of exercise. Exercise and mineral accrual. Acta Univ Carol Med (Praha). 1994 ; 40: 3-6.
58. Lloyd T., Petit MA, Lin HM, Beck TJ Lifestyle factors and the development of bone mass and bone strength in young women. J Pediatr. 2004 ; 144: 776-782.
59. Lloyd T., Chinchilli VM, Johnson-Rollings N., Kieselhorst K., Eggli DF, Marcus R. Adult female hip bone density reflects teenage sports-exercise patterns but not teenage calcium intake. Pediatrics. 2000 ; 106: 40-44.
60. Robinson RJ, Krzywicki T., Almond L., et al. Effect of a low-impact exercise program on bone mineral density in Crohng's disease: a randomized controlled trial. Gastroenterology. 1998 ; 115: 36-41.
61. Rauch F., Plotkin H., Zeitlin L., Glorieux FH Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy. J Bone Miner Res. 2003 ; 18: 610-614.
62. Glorieux FH, Bishop NJ, Plotkin H., Chabot G., Lanoue G., Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998 ; 339: 947-952.
63. Glorieux FH Bisphosphonate therapy for severe osteogenesis imperfecta. J Pediatr Endocrinol Metab. 2000 ; 13 (suppl 2). 989-992.
64. Wirth SM, Lawson AP, Sutphin SD, Adams VR, Smith KM Osteonecrosis of the jaw associated with bisphosphonate therapy. Orthopedics. 2009 ; 32: 900-903.
65. WHO Study Group. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Geneva, Switzerland: World Health Organization ; 1994.